Mylan Seeks Approval for Generic Advair Diskus


Mylan has submitted an abbreviated new drug application to the FDA for a generic equivalent to GlaxoSmithKline's Advair Diskus.

Mylan has submitted an abbreviated new drug application to the FDA for a generic equivalent to GlaxoSmithKline’s Advair Diskus.

If approved, Mylan would be able to manufacture and market fluticasone propionate 100, 250, and 500 mcg and salmeterol 50 mcg inhalation powder.

Advair Diskus is currently indicated for patients 4 years and older who have asthma or who need maintenance treatment of airflow obstruction.

Advair Diskus can also reduce exacerbations for patients with chronic obstructive pulmonary disease.

The most common adverse effects from using the Advair Diskus product include upper respiratory tract infection, throat irritation, and voice hoarseness. In some cases, it may also lead to fungal infections in the mouth or throat, pneumonia, a weakening of the immune system, or reduced adrenal function.

Related Videos
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U -
Image credit: Andrea Izzotti
Inflation Reduction Act is shown using the text and the US flag - Image credit: Andrii |
Pharmacy Interior | Image Credit: Tyler Olson -
Male pharmacist selling medications at drugstore to a senior woman customer | Image Credit: Zamrznuti tonovi -
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen |
Pharmacy, medicine and senior woman consulting pharmacist on prescription. Healthcare, shopping and elderly female in consultation with medical worker for medication box, pills or product in store - Image credit: C Daniels/ |
Image credit: fidaolga -
Pharmacists checking inventory at hospital pharmacy- Image credit: Jacob Lund |
Young male pharmacist giving prescription medications to senior female customer in a pharmacy | Image Credit: Zamrznuti tonovi -
© 2023 MJH Life Sciences

All rights reserved.